Suzanne Sawochka Hooper's Insider Trades & SAST Disclosures
Suzanne Sawochka Hooper's most recent trade in Ngm Biopharmaceuticals Inc was a trade of 78,407 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Suzanne Sawochka Hooper.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 78,407 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 38,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 24,222 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 24,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 19,619 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 16,806 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | 05 Apr 2024 | 7,000 | 0 (0%) | 0% | - | Common Stock | ||
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 24,222 | 24,222 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 19,619 | 19,619 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Suzanne Sawochka Hooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 16,806 | 16,806 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges